Total Company Value: TC Biopharm (TCBP)

This daily price chart for TC Biopharm (TCBP) reflects a business valuation that currently stands at . TC Biopharm (TCBP) is developing affordable methods to combat hematological tumors using universal healthy donor cells. A strong team of immunologists, incentivized by a stock option system, ensures the stability of these developments. This approach enables the rapid deployment of "off-the-shelf" drugs, eliminating the need for lengthy, individualized therapy preparation for each patient.

Fundamental asset selection requires an analysis of the enterprise value, which combines market capitalization and net debt to determine the actual acquisition price. This metric allows for an assessment of whether the value of TC Biopharm (TCBP) cell therapy patents justifies current expenditures and debt load, as clearly reflected in the company's gross value dynamics.